May 12, 2021
RFA-HL-20-006 - Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
The purpose of this Notice is to inform potential applicants that a set of responses to Frequently Asked Questions (FAQs) regarding RFA-HL-20-006 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed) has been posted at the following link: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/RFA-HL-20-006.
Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.
David Schopfer, M.D.
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-402-3833
Email: David.schopfer@nih.gov
Qing Lu, DVM, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Phone: 301-480-9158
Email: qing.lu@nih.gov
Mark Damico, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5630
Email: mark.damico@nih.gov
Roya Kalantari, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-594-5945
Email: roya.kalantari@nih.gov
Basil Eldadah, M.D., Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-6761
Email: basil.eldadah@nih.gov